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An Integrative Common Liabilities Model for the Comorbidity of Substance Use Disorders with 
Externalizing and Internalizing Disorders  
Erin C. Tully 
William G. Iacono 
University of Minnesota 
 
Abstract 
This paper presents an integrative research-derived model to explain comorbidity among SUDs, 
externalizing disorders, and internalizing disorders. This hierarchical model is based on 
phenotypic covariance among the disorders and latent common genetic liability. At the highest 
level of the hierarchy, general genetically-influenced biological dispositions to negative 
emotionality and behavioral disinhibition each give rise to spectra of related personality traits, 
cognitive processes, behavioral tendencies, and psychopathology that account for the pattern of 
co-occurrence among mental disorders. At the lowest level of the hierarchy, disorder-specific 
genetic and environmental effects explain the presence of some and not other disorders 
associated with a given general liability. Interplay between the general liabilities and both other 
genes and environmental factors throughout development affect the likelihood of developing 
specific mental disorders. 
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1. Introduction 
 Comorbidity, or the tendency for disorders to co-occur at greater than chance rates 
(Clark, Watson, & Reynolds, 1995), is high among psychiatric disorders, with estimates that 
nearly 60% of individuals with a lifetime DSM-IV psychiatric disorder have diagnoses of more 
than one disorder (Kessler, Berglund, Demler, Jin, & Walters, 2005). Drug and alcohol use 
disorders are frequently comorbid with each other, and rates of substance use disorders (SUDs) 
are nearly three times as common among individuals with psychiatric disorders compared to 
individuals with no psychiatric disorder (Regier et al., 1990). Estimates from the National 
Comorbidity Survey-Replication (NCS-R) study indicate that SUDs are comorbid with antisocial 
disorders, mood disorders, and anxiety disorders. The likelihood of having a SUD was increased 
by six times among individuals with Conduct Disorder (CD; Nock, Kazdin, Hiripi, & Kessler, 
2006), and last 12-month diagnoses of SUDs were about six to seven times more common 
among individuals with Antisocial Personality Disorders (ASPD; Lenzenweger, Lane, Loranger, 
& Kessler, 2007). Twenty-four percent of individuals with lifetime major depressive disorder 
(MDD) had a lifetime SUD diagnosis (Kessler et al., 2003), compared to lifetime estimates of 
14.6% for SUDs in the general population (Kessler et al., 2005). The likelihood of having a SUD 
was 2.2 to 4.8 times greater among individuals with panic disorders (PD) and/or agoraphobia 
(Ago; Kessler et al., 2006), and subsequent  SUDs were about twice as likely for individuals with 
Generalized Anxiety Disorder (GAD; Ruscio et al., 2007).   
  A great deal is known about the etiology of SUDs, including the typical developmental 
progression from behavioral and neurobiological predispositions to the emergence of SUDs 
during adolescence and early adulthood and the importance of both genetic and environmental 
influences on risk for SUDs. Considerably less is known about the origins of comorbidity with 
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SUDs. This chapter provides a comprehensive review of the literature and describes an 
integrative  model (Figure 1) to explain comorbidity among SUDs and other common mental 
disorders. The model is based on three central principles: (1) risk for psychopathology is 
multifactorial, reflecting cumulative effects of gene-environment interplay that begins in 
childhood and early adolescence, (2) covariance among common mental disorders is captured by 
two broad hierarchically organized dimensions characterized by externalizing and internalizing 
tendencies, and (3) the organization of this hierarchical system derives from genetically 
influenced biological dispositions to negative emotionality and at a lower level of the hierarchy 
to behavioral disinhibition, negative thought processes, and physiological hyperarousal. Our 
main thesis is that comorbidity can largely be explained by genetic liabilities for biological 
processes that give rise to these externalizing and internalizing dimensions, each of which is 
composed of related personality traits, cognitive processes, behavioral tendencies, and symptoms 
of psychopathology. In the sections that follow, we review empirical and theoretical support for 
this model from a developmental perspective and then describe how the model explains the 
comorbidity of SUDs with other psychiatric disorders. We begin by reviewing research on the 
underlying covariance structure of psychopathology, which forms the basis for the hierarchical  
common liabilities model.  
2. Common Genetic Liabilities 
 The high comorbidity among psychiatric disorders suggests that psychopathology is 
encompassed by a smaller number of higher order constructs. Multivariate twin studies have 
modeled the covariance of depression, anxiety, substance use, and antisocial disorders to identify 
the latent structure underlying comorbidity. In these studies, the amount of genetic influence 
shared among different disorders is calculated by comparing monozygotic and dizygotic twin 
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pairs on the degree of association between a phenotype (e.g., alcohol dependence) in one twin 
and a different phenotype (e.g., ASPD) in the co-twin. Shared genetic influences can be inferred 
when monozygotic twins have greater cross-phenotype similarity than dizygotic twins. 
 A meta-analysis of these multivariate studies (Krueger & Markon, 2006) revealed a best-
fitting model with two correlated superordinate factors underlying two broad spectra of 
disorders: (a) an externalizing (EXT) spectrum/factor that encompasses antisocial deviance (i.e., 
CD and ASPD) and substance abuse/dependence and is described as the propensity to express 
distress outward, and (b) an internalizing (INT) spectrum/factor that encompasses depressive 
(MDD and dysthymia) and anxiety disorders (GAD, phobias, PD) and is described as a 
propensity to express distress inward. In the best-fitting model, this INT factor was further 
subdivided into two highly correlated but distinct subfactors. One INT factor, which we have 
labeled anhedonia/misery (INT-AM), underlies the covariance of MDD, persistent depressive 
disorder (formerly dysthymic disorder), and GAD; and the second INT factor, which we have 
labeled fear/arousal (INT-FA), underlies agoraphobia, social anxiety disorder, specific phobia, 
and panic disorder.1 PD had a modest loading on the INT-AM factor as well, and given that other 
large multivariate twin studies (e.g., Kendler, Prescott, Myers, & Neale, 2003) find that PD loads 
more strongly onto a factor with MDD and GAD, PD is depicted with loadings on both INT 
subfactors in our common liabilities model.  
 Twin and adoption studies support the substantial role of genes in the etiology of mental 
disorders. In childhood and early adolescence, genes contribute to individual differences in traits 
like aggression, inattention, and fearfulness (Bartels et al., 2007; Hirata, Zai, Nowrouzi, 
Beitchman, & Kennedy; 2013; Trzaskowski, Zavos, Haworth, Plomin, & Eley, 2012; 
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Zai, Ehtesham, Choi, Nowrouzi, de Luca, Stankovich, et al., 2012), which are predictive of 
psychopathology later in adolescence and adulthood (e.g., Ormel et al., 2005; Pardini, Lochman, 
& Wells, 2004). Genetic factors contribute to disruptive behavior disorders, anxiety disorders, 
and depressive disorders in youth (Ehringer, Rhee, Young, Corley, & Hewitt, 2006), and by 
adulthood, SUDs, antisocial behavior disorders, depressive disorders, and anxiety disorders are 
at least moderately heritable (Fu et al., 2002; Goldman, Oroszi, & Ducci, 2005; Hettema, 
Prescott, Myers, Neale, & Kendler, 2005; Sullivan, Neale, & Kendler, 2000; Tully, Iacono, 
McGue, 2010). The hierarchical INT/EXT structure suggests that disorders that load onto the 
same factor share common core processes, and research suggests that these shared processes are 
likely genetically influenced. Kendler et al.’s (2003) study showed that the distinction between 
the INT and EXT factors was largely genetic rather than environmental in nature and that the two 
INT subfactors had distinct, although positively correlated, genetic loadings (Kendler, Prescott, 
Myers, & Neale, 2003). 
 Disorders are most highly comorbid with other disorders with loadings on the same factor 
(Kessler et al., 2005). However, disorders that load onto different factors are also comorbid, 
albeit to a lesser extent. This cross-factor comorbidity reflects the fact that the INT and EXT 
factors are moderately correlated (r = .50; Krueger & Markon, 2006) and suggests shared 
etiology of disorders across factors. In our common liabilities model, comorbidity of INT and 
EXT disorders is largely explained by a general liability that influences risk for INT and EXT 
disorders. The higher comorbidity of disorders loading on the same factor is explained by 
additional genetic liabilities shared only among disorders of the EXT factor, the INT-AM 
subfactor, or the INT-FA subfactor. Environmental factors are also proposed to contribute to the 
etiology of mental disorders, and some environmental factors (e.g., high levels of stress) increase 
6 
 
risk for various mental disorders and thus contribute to comorbidity. In addition, unique genetic 
and environmental risks specific to each disorder account for multifinality (Cicchetti & Rogosch, 
1996). In other words, they explain why individuals with the same general liability do not all 
experience the same outcomes.  We begin our discussion of common genetic liabilities with the 
highest order liability that accounts for comorbidity across the INT and EXT factors.  
2.1 Negative Emotionality Liability  
 Although best-fitting models from multivariate analyses of covariance identify two 
higher order latent factors, the cross-factor comorbidity and correlation between the two factors 
suggest the possibility of a higher order liability that influences disorders in both the INT and 
EXT factors. We posit that comorbidity between SUDs and both externalizing and internalizing 
psychopathology is due in part to a general, genetically influenced liability, which we have 
labeled negative emotionality (NE). This general liability is expressed as a spectrum of 
neurobiological processes, personality traits, and behavioral tendencies common to both INT and 
EXT disorders, such as proneness to experiencing negative emotions like sadness and anger, 
propensities toward inadequate emotion regulation abilities, and maladaptive responses to 
negative emotions and stress.  
 Support for NE as a general liability is derived from findings of genetic influences on 
variables related to the NE construct and from studies of NE-related personality traits underlying 
both INT and EXT disorders. For example, neuroticism is a personality trait characterized by 
emotional instability, vulnerability to stress, and proneness to anxiety (Eysenck, Eysenck, & 
Barrett, 1985). Neuroticism is heritable (e.g., Birley et al., 2006) and has been associated with 
depression and anxiety (Gershuny & Sher, 1998; Hettema, Neale, Myers, Prescott, & Kendler, 
2006; Kendler, Gardner, & Prescott, 2002; 2006; Kendler, Gatz, Gardner, & Pedersen, 2006; 
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Klein, Kotov, & Bufferd, 2011), antisocial behavior (Derefinko & Lynam, 2006; Hicks & 
Patrick, 2006; Taylor, Reeves, James, & Bobadilla, 2006), and SUDs (Agrawal, Jacobson, 
Prescott, & Kendler, 2004; Elkins, King, McGue, & Iacono, 2006; Jackson & Sher, 2003; Hur, 
2009; James & Taylor, 2007; Miller, Vogt, Mozley, Kaloupek, & Keane, 2006). It has also been 
found to account for a significant proportion of the comorbidity between INT and EXT disorders 
(Khan, Jacobson, Gardner, Prescott, & Kendler, 2005).  In addition, Tellegen (1982) proposed a 
similar construct, also labeled negative emotionality, which is defined as a tendency to 
experience negative emotions and to become behaviorally dysregulated under stress. Negative 
emotionality  prospectively predicts alcohol and marijuana dependence, CD, ASPD, depressive 
disorders, and anxiety disorders (Krueger, 1999a; Slutske et al., 2002; Tellegen, 1982).  
 Research on endophenotypes provides further support for shared NE-related genetic 
origins of INT and EXT disorders. Endophenotypes are attributes that are a product of genotypes 
that predispose to a disorder and are presumed to be more proximal to the genetic influences than 
clinical diagnoses themselves (Gottesman & Gould, 2003; Iacono & Malone, 2011). Disorders 
associated with the same endophenotypes likely share some of the same genetic influences 
(Yoon, Iacono, Malone, & McGue, 2006). Accurate identification of endophenotypes ultimately 
requires research at the molecular level, but indices of biological processes (e.g., 
psychophysiology measures, levels of hormones and neurotransmitters) that are correlated with 
clinically relevant phenotypes and genetically influenced are plausible endophenotypes. Many 
neurobiological systems associated with NE, in particular anger and responses to stress are 
common to both INT and EXT disorders. Corticotropin-releasing factor (CRF), the 
hypothalamic-pituitary-adrenal (HPA) axis, and noradrenergic pathways are involved in the 
body’s stress response system and have been implicated in the pathophysiology of anxiety, 
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mood, and addictive disorders (for review see Brady & Sinha, 2005).  Anger is largely regulated 
by dopaminergic and glutamate systems in the nucleus accumbens and prefrontal cortex, and 
neuroimaging and psychopharmacological treatment studies suggest that these systems also play 
a role in the neurobiology of depressive, anxiety, behavioral, and SUDs (for reviews see Koob et 
al., 2004; Lara & Akiskal, 2006). Moreover, serotonin, dopamine, and CRF have been implicated 
in the etiology of substance-induced depression and anxiety (e.g., Markou , Kosten, & Koob, 
1998; Rounsaville, 2004; Zoltgn et al., 1995), thus providing more evidence for common 
endophenotypes for INT disorders and SUDs. The genetic basis of these neurobiological 
substrates and systems is supported by association studies of candidate genes involved in the 
stress response, particularly functional polymorphisms related to monoaminergic 
neurotransmission (e.g., in the loci encoding the serotonin transporter, tyrosine hydroxylase, 
catechol-o-methyltransferase, glucocorticoid receptor; for review see Levinson, 2006), and by 
research on phenotypic outcomes resulting from modifications of serotonin-related genes in 
rodents (for review see Holmes, 2008). These studies support the role of stress response 
polymorphisms in the neurobiology of neuroticism (Levinson, 2006), depression (Brouwer et al., 
2006; Joensuu, et al., 2010; Levinson, 2006; Sarosi et al., 2008), and alcohol-related disorders 
(Clarke et al., 2008; Florez et al., 2008; Merenäkk, et al., 2011).  
 Understanding how NE liability contributes to high co-occurrence among disorders 
requires a developmental perspective. Trait negative emotionality is relatively stable from 
infancy through adulthood (Lonigan, Phillips, & Hooe, 2003; Pedlow, Sanson, Prior, & 
Oberklaid, 1993; Roberts & DelVecchio, 2000; Rothbart, Ahadi, & Evans, 2000), this stability is 
genetically mediated (e.g., Spengler, Gottschling, Spinath, 2012), and associations between NE-
related constructs and psychopathology begin early in development. Dispositional measures of 
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negative emotions, such as tendencies toward sadness, anger, irritability, and frustration, have 
been associated with internalizing and externalizing problems in young children (Eisenberg et 
al., 2001), preadolescents (Anthony & Lonigan, 2002; Oldehinkel, Hartman, Winter, Veenstra, & 
Johan, 2004), and adolescents (Silk, Steinberg, & Morris, 2003). Measures of negative emotions 
early in childhood  prospectively predict higher levels of psychopathology in late adolescence 
(Block, Gjerde, & Block, 1991) and young adulthood (Caspi, Moffitt, Newman, & Silva, 1996), 
and negative emotionality in late adolescence predicts subsequent development of major 
depression in adulthood (Wilson, DiRago, & Iacono, 2013). In one study, examiners rated 
children’s behavior at age 3 in an unselected Dunedin birth cohort sample. Factor and cluster 
analyses of these ratings revealed five behaviorally and emotionally distinct groups of children 
that differed in psychiatric diagnoses at age 21. Behaviorally inhibited children were most likely 
to grow up to have depression diagnoses, and behaviorally undercontrolled children were most 
likely to have diagnoses of alcohol dependence and ASPD. Both of these groups were 
characterized by high negative emotions, including fear and stranger distress for the inhibited 
group and irritability and emotionally liability for the undercontrolled group. Importantly, the 
three groups with low levels of psychiatric problems at age 21 did not have high levels of 
negative emotions, including a reserved group of children who were behaviorally comparable to 
the inhibited group but were not described as having fear and distress (Caspi et al., 1996). These 
findings highlight the role of NE in early developmental pathways leading to psychopathology 
and also suggest a mediating role of inadequate strategies for regulating and processing negative 
emotions.  
 The common liabilities model proposes that the general NE liability influences risk for 
INT and EXT disorders both directly by predisposing individuals to experience and express 
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negative emotions and indirectly through interactions with genes for lower order genetic 
liabilities specific to the INT and EXT factors, in particular liabilities related to the regulation of 
behavior, emotion, and thoughts. Regulation difficulties for individuals with EXT disorders lead 
them to express the NE liability as dysregulated external behaviors (e.g., aggression toward 
others, illicit substance use), whereas regulation difficulties for individuals with INT disorders 
lead them to experience the NE liability as internal dysregulation (e.g., rumination, excessive 
attention to negative information, persistent distress). In this way, the NE factor increases the 
likelihood that INT or EXT factor-specific genes will be expressed as INT or EXT disorders, 
thus contributing to the comorbidity of disorders falling into the INT or EXT spectra.  
2.2 Regulation Liabilities 
 In the common liabilities model, the genetic liability for NE—the propensity to 
experience negative emotions—typically interacts with genetic liabilities underlying three types 
of emotion regulation difficulties to predict psychopathology. More specifically, the shared NE 
liability interacts with a liability to behavioral disinhibition (BD), which predisposes individuals 
to have difficulty regulating their behavioral responses to negative emotions and increases risk 
for externalizing disorders; and liabilities to negative thinking (NT) and physiological 
hyperarousal (PH), which predispose individuals to have difficulty internally regulating and 
processing negative emotions and increases risk for internalizing disorders. Theory and research 
from the developmental literature support this idea that internalizing and externalizing symptoms 
stem from a combination of propensities to experience negative emotions and propensities 
toward inadequate control of these emotions. Various models of child temperament propose both 
reactive traits (e.g., automatic behaviors and unregulated fear) and effortful or active traits (e.g., 
self-regulation abilities and purposeful attentional focus) as components of developmental paths 
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leading to psychopathology (Derryberry & Rothbart, 1988; 1997; Kochanska, Barry, Jimenez, 
Hollatz, & Woodard, 2009; Lonigan et al., 2004; Muris & Ollendick, 2005; Rothbart, 1989; 
Rothbart, Ahadi, & Hershey, 1994; Rothbart, Posner, & Hershey, 1995). A study involving a 
Dutch population-based sample of adolescents found that predispositions toward low effortful 
control (i.e., tendencies to voluntarily inhibit a dominant response in order to perform a 
subdominant but more adaptive response) magnified the effect of fearfulness on internalizing 
problems and the effect of frustration on externalizing problems in adolescents (Oldehinkel, 
Hartman, Ferdinand, Verhulst, & Ormel, 2007), and effortful control and negative affect were 
associated with familial loadings for both internalizing and externalizing psychopathology 
(Ormel et al., 2005). In the next two sections, we describe the regulation liabilities in greater 
detail from a developmental perspective. 
2.2.1 Behavioral Disinhibition Liability for Externalizing Disorders 
 The EXT latent factor has been associated with low constraint in Tellegen’s (1982) 
personality model (Krueger, McGue, & Iacono, 2001), indicating that individuals high in EXT 
tend to be impulsive and thrill-seeking and have low adherence to traditional moral values. The 
common liabilities model proposes that the high comorbidity among externalizing disorders is 
due to a common genetic liability for traits, behaviors, disorders, and endophenotypes that reflect 
a propensity toward behavioral disinhibition (BD), such as inattention, aggressiveness, 
impulsivity, and low persistence (for a complete review see Iacono, Malone, & McGue, 2008). 
 Twin and adoption studies support shared genetic influences underlying the traits and 
disorders in the EXT spectrum. Multivariate studies indicate shared genetic influences 
underlying dependence on various licit substances (Agrawal et al., 2007; Lynskey et al., 2007; 
Swan, Carmelli, & Cardon, 1996; True, Xian et al., 1999), common genetic influences on 
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different drugs in the illicit substance classes (Agrawal, Neale, Prescott, & Kendler, 2004a; 
Karkowski, Prescott, & Kendler, 2000; Kendler, Aggen, Tambs, & Reichborn-Kjennerud, 2006; 
Kendler, Jacobson, Prescott, & Neale, 2003; Tsuang et al., 1998), and either shared genetic 
influences on dependence across licit and illicit substances (Agrawal & Lynskey, 2006; Hopfer, 
Crowley, & Hewitt, 2003; True, Heath et al., 1999) or highly correlated genetic influences on 
licit and illicit factors (r = .82; Kendler, Myers, & Prescott, 2007).  Other studies support 
significant genetic covariation between SUDs and disruptive behavior disorders in childhood 
(Burt, Krueger, McGue, & Iacono, 2001; Button et al., 2006; Button et al., 2007; Dick, Viken, 
Kaprio, Pulkkinen, & Rose, 2005; Nadder, Rutter, Silberg, Maes, & Eaves, 2002; Silberg et al., 
1996) and between SUDs and adult antisocial behavior disorders (Hicks, Foster, Iacono, & 
McGue, 2013; Hicks, Krueger, Iacono, McGue, & Patrick, 2004). Moreover, latent EXT factors 
comprised of SUDs and antisocial disorders are highly heritable (Hicks et al., 2007; Hicks, 
Schalet, Malone, Iacono, & McGue, 2011; Kendler, Prescott et al., 2003). Finally, research 
supports shared genetic risks underlying EXT disorders and other behavioral disinhibition 
attributes, such as the personality traits of novelty seeking (Khan et al., 2005) and behavioral 
undercontrol (Krueger et al., 2001; Slutske et al., 2002), and early adolescent problem behaviors 
like substance experimentation and use, sexual intercourse, and police contact (Keyes, Iacono, & 
McGue, 2007; McGue, Iacono, & Krueger, 2006; Young, Stallings, Corley, Krauter, & Hewitt, 
2000). 
 Research on biologically based endophenotypes provides further support for a common 
EXT genetic liability. Reduced amplitude of the P300 wave, a nonspecific index of brain 
activity, is a well-studied endophenotype that has been associated with childhood disruptive 
behavior disorders and antisocial personality disorder (Iacono, Carlson, Malone, & McGue, 
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2002), substance misuse and SUDs (Carlson, McLarnon, & Iacono, 2007; Iacono et al., 2002; 
Yoon et al., 2006), and the externalizing latent trait (Patrick, 2006). Although the biological 
systems  underlying individual differences in the P300 wave (Burwell, Malone, Bernat, & 
Iacono, 2014) are not well understood, individual differences in P300 amplitude predict 
subsequent development of EXT disorders (Iacono et al., 2002; Perlman, Markin, & Iacono, 
2013), are heritable (van Beijsterveldt & van Baal 2002; Perlman, Johnson, & Iacono, 2009; van 
Beijsterveldt & van Baal, 2002; Yoon et al., 2006), and the association between attenuated P300 
amplitude and externalizing disorders is genetically mediated (Hicks et al., 2007a).  
 The midbrain dopamine reward system is a neurobiological mechanism involved in 
addiction to virtually all drugs of abuse (Kosten, George, & Kleber, 2005; Nestler, 2005) that has 
been proposed to underlie aggressive behavior as well (Patrick, 2006), which provides further 
support for genetic liability shared among SUDs and antisocial disorders. Consistent with this, 
Gray’s model of motivational systems proposes two neurologically based personality systems: 
(a) the behavioral activation system (BAS), which is exhibited as sensitivity to rewards and 
motivation to engage in goal-directed efforts to experience positive feelings; and (b) the 
behavioral inhibition system (BIS), which refers to sensitivity to punishments and proneness to 
inhibit behavior that may lead to negative or painful outcomes (Gray, 1972; 1975; 1981).  EXT 
disorders likely reflect increased BAS activation, in the form of midbrain reward system, and 
decreased BIS activation (Iacono et al., 2008), which is likely related to diminished prefrontal 
cortex functioning and difficulty regulating behavior and inhibiting inappropriate responses 
(Bechara, 2005; Miller & Cohen, 2001). BIS and BAS impairment across EXT disorders 
underlies high comorbidity among EXT disorders, whereass cross-disorder differences in 
BIS/BAS impairment is related to different outcomes among individuals with the BD liability. 
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Individuals with SUDs tend to have more BAS problems, individuals with antisocial disorders 
tend to have more BIS problems, and individuals with comorbid SUDs and antisocial disorders 
tend to have problems with both systems. 
 Consideration of developmental research is again key to understanding how this genetic 
liability contributes to comorbidity. The BD liability is expressed as different phenotypes over 
the course of development with the same early temperament traits predicting various subsequent 
EXT disorders. Behavioral disinhibition traits, such as lack of inhibitory control, novelty 
seeking, and low harm avoidance, when expressed during early childhood predict subsequent 
substance use and misuse during adolescence (Caspi, Henry, McGee, Moffitt, & Silva, 1995; 
Caspi et al., 1996; Masse & Tremblay, 1997; Wong et al., 2006), and the same traits assessed 
during late childhood, adolescence, and young adulthood predict tobacco, alcohol, and illicit 
drug symptoms and disorders in later in adulthood (Chassin, Fora, & King, 2004; Cloninger, 
Sigvardsson, & Bohman, 1988; Elkins et al., 2006; Grekin, Sher, & Wood, 2006; Krueger, 
1999a; Sher, Bartholow, & Wood, 2000). These traits also manifest as disruptive behavior 
disorders (e.g., Oppositional Defiant Disorder, CD) during childhood (Young, et al., 2009), 
which are predictive of later SUDs (Kim-Cohen et al., 2003; Weinberg, Rahdert, Colliver, & 
Glantz, 1998), and as high-risk behaviors during early adolescence, such as antisocial behavior, 
experimentation with alcohol, precocious sexual activity, and academic difficulty, which in turn 
predict later SUDs and ASPD (Grant & Dawson, 1997; McGue & Iacono, 2005).  
 These early universal EXT traits become more differentiated across development. Caspi 
et al. (1995) found one latent factor for lack of control at ages 3 and 5 that became 2 distinct 
factors (an impulsive/undercontrolled factor and a fleeting attention/lack of persistence factor) by 
ages 7 and 9 (Caspi et al., 1995). Likewise, a longitudinal study investigating change in the 
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underlying structure of the EXT factor from age 17 to 24 found a decrease in the amount of 
overlapping variance among externalizing disorders with age (Hicks et al., 2007), reflecting 
decreased genetic influence on the covariation among disorders (Vrieze, Hicks, Iacono, & 
McGue, 2012). In addition, greater differentiation with age may be due to varied environmental 
risk exposure and age-related expression of genes that are specific to certain externalizing 
attributes (Agrawal, Neale, Prescott, & Kendler, 2004b; Grant et al., 2006; Hicks et al., 2004; 
Kendler, Prescott et al., 2003; Krueger et al., 2002; McGue et al., 2006; Young et al., 2000). 
These disorder-specific effects account for relative differences in the extent to which the shared 
liabilities contribute to the development of specific disorders and explain why only some and not 
other externalizing disorders appear in a given individual with the BD liability. For example, 
individuals with extreme antisocial tendencies are likely to be high in BD and relatively low in 
NE (Patrick, 2006).  
2.2.2 Liability for Internalizing Disorders 
 Genetic risk factors associated with NE contribute substantially to the genetic overlap 
among internalizing disorders (Bienvenu, Hettema, Neale, Prescott, & Kendler, 2007; Fanous, 
Gardner, Prescott, Cancro, & Kendler, 2002; Fanous, Neale, Aggen, & Kendler, 2007; Gillespie 
& Martin, 2006; Hansell, et al., 2012; Hettema, Neale et al., 2006; Hettema, Prescott, & Kendler, 
2004; Kendler & Gardner, 2011; Levinson, 2006). Therefore, we do not propose a specific 
liability for the INT factor but rather propose that the NE liability has a strong genetic influence 
on the internalizing factor and underlies all  depressive and anxiety disorders. Consistent with the 
multivariate twin studies, we posit two subfactor-specific genetic liabilities. A liability to 
physiological hyperarousal (PH) underlies the disorders in the fear/arousal subfactor (i.e., 
agoraphobia, social phobia, specific phobia, and PD) and is expressed as 
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psychophysiological/somatic signs, fear, heightened attention to threats, and behavioral 
inhibition. A liability to negative thought processes (NT), including worry, rumination, and 
negatively biased attention and interpretation, underlies disorders in the anhdeonia/misery 
subfactor (i.e., MDD, persistent depressive disorder, GAD, and PD) and is expressed as habitual 
negative attributions and expectations and low positive affect. 
 This structure for a general NE liability and subfactor-specific PH and NT liabilities is 
similar to the tripartite model (Clark & Watson, 1991) and the integrative hierarchical model 
(Mineka, Watson, & Clark, 1998). The tripartite model proposes a general distress/negative 
affectivity dimension that is common to both depression and anxiety disorders as well as an 
anhedonia (low positive affect) factor specific to depression and a physiological hyperarousal 
factor specific to anxiety. Our integrative hierarchical model combines elements of the tripartite 
model and Barlow’s hierarchical organization of the anxiety disorders (Barlow, 1991; Zinbarg & 
Barlow, 1996) and posits that each anxiety and depressive disorder contains both a common 
component and a unique component. These models propose a general negative affectivity factor 
that accounts for a large proportion of variance in MDD and GAD and a much smaller 
proportion of the variance in most other anxiety disorders (e.g., social phobia, specific phobia) 
and that negative affectivity and low positive affectivity characterize many noninternalizing 
disorders. Watson (2005) further proposed a quantitative hierarchical model  in which a general 
emotion disorders category can be subdivided into the bipolar disorders (bipolar I, bipolar II, 
cyclothymia), the distress disorders (MDD, dysthymic disorder, GAD, and PTSD), and the fear 
disorders (panic disorder, agoraphobia, social phobia, and specific phobia; Watson, 2005).  
 Analogous to the developmental progression of the BD liability, behavioral inhibition, 
specifically when it is characterized by poor autonomic regulation (Marshall & Stevenson-Hinde, 
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1998), typically appears during early childhood in individuals who will later develop anxiety 
(Hirshfeld-Becker et al., 2007; McDermott, et al., 2009), and anxiety may be an earlier 
expression of the common NE liability than depression. Anxiety is more likely than depression 
to onset during childhood, depression in child and adolescent samples is most often comorbid 
with anxiety (Anderson, Williams, McGee, & Silva, 1987; Angold, Costello, & Erkanli, 1999; 
Fleming, Offord, & Boyle, 1989), and the onset of anxiety tends to precede the onset of 
depression (Hettema, Kuhn et al., 2006; Kessler et al., 2005; Woodward & Fergusson, 2001). 
Twin studies of children and adolescents support significant genetic covariation between anxiety 
and subsequent depression that cannot be explained by genetic influences associated with earlier 
depression (Eaves et al., 2003; Rice et al., 2004), suggesting shared genetic etiology of childhood 
anxiety and later depression. Anxiety and depression do not always co-occur and anxiety does 
not always precede depression, but these findings support a common liability underlying the two 
separate INT subfactors.    
 Research on associations between temperament/personality traits and depressive and 
anxiety disorders supports the PH and NT liabilities. Many concurrent and a few prospective 
studies of children and adolescents have consistently found associations between high negative 
affect/neuroticism and both depression and anxiety, low positive affect/surgency and depression, 
and high physiological arousal and anxiety (e.g., Caspi et al., 1996; Chorpita & Daleiden, 2002; 
Compas, Conner-Smith, & Jaser, 2004; Lonigan, Carey, & Finch, 1994). Studies involving adult 
samples have similar findings. Internalizing factors defined by both depression and anxiety 
symptoms tend to have smaller correlations with positive emotionality than with negative 
emotionality (Krueger et al., 2001). Krueger (1999b) found a significant negative association 
between depressive disorders and the well-being dimension of Tellegen’s Multidimensional 
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Personality Questionnaire (which is described as cheerfulness, optimism, and proneness to 
enjoyment) and no association between well-being and anxiety disorders (Krueger, 1999a). In a 
similar way, constraint, a personality factor defined as a propensity for cautious and restrained 
behavior and endorsement of traditional values, does not typically correlate with the general INT 
factor (Krueger et al., 2001), and high constraint is characteristic of individuals with anxiety 
disorders but not depressive disorders (Krueger, 1999a). Consistent with the specificity of 
constraint to the PH liability, Gladstone et al. (2006) found that social anxiety mediated the  
relationship between childhood inhibition and later depression (Gladstone, Parker, Gladstone, & 
Parker, 2006). 
2.2.2.1 Physiological Hyperarousal Liability. Some anxiety is normative, particularly in 
infancy and toddlerhood in response to separation from parents. This fear typically diminishes 
dramatically during early childhood (Muris, Meesters, Merckelbach, Sermon, & Zwakhalen, 
1998), an age when fear-based anxiety disorders, such as separation anxiety disorder, social 
phobia, and specific phobias, are likely to onset (Kessler et al., 2005). Fear in these young 
children has significant genetic overlap with shyness/inhibition (62%) and negative mood (53%; 
Eley et al., 2003), suggesting developmental continuity with later internalizing disorders that 
share these traits, particularly disorders in the FA subfactor. These disorders are characterized by 
behavioral constraint (Krueger, 1999a) and intense physiological hyperarousal (PH), such as 
heart racing, sweating, and shortness of breath particularly in response to stressors (Cuthbert et 
al., 2003; Hofmann, Moscovitch, & Kim, 2006; Martin-Soelch, Stocklin, Dammann, Opwis, & 
Seifritz, 2006). 
Turning to evidence of potential endophenotypes, research on psychophysiological 
characteristics of anxious and depressed individuals supports the distinction of the PH and NT 
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liabilities within internalizing psychopathology. Anxiety disorders loading on the FA factor are 
characterized by poor parasympathetic flexibility (Licht, de Geus, van Dyck, & Penninx, 2009; 
Sharma, Balhara, Sagar, Deepak, & Mehta, 2011) and exaggerated sympathetic arousal to 
affectively arousing stimuli, especially fear stimuli (Cuthbert et al., 2003; Larson, Nitschke, & 
Davidson, 2007). Cuthbert et al. (2003) found that individuals with PD were less physiologically 
responsive to the affective stimuli than individuals with specific phobias and social anxiety, a 
finding that is consistent with PD’s relatively smaller genetic loading on the FA factor (Kendler, 
Prescott et al., 2003). Moreover, depressed individuals without anxiety disorders and anxious 
individuals with worry or anhedonic symptoms but not arousal symptoms do not show 
exaggerated physiological responses to these stimuli (Larson et al., 2007), and researchers have 
found blunted physiological responses to pleasant stimuli among individuals with depression 
(Forbes, Miller, Cohn, Fox, & Kovacs, 2005; Larson et al., 2007). A comprehensive review of 
this literature supports these conclusions (Vaidyanathan, Patrick, & Cuthbert, 2009) and links the 
differentiation of INT disorders to distinct underlying brain systems.  Few studies have 
investigated the heritability of these psychophysiological indices. The extant literature supports 
modest genetic influences on conditioned eyeblink responses (Merrill, Steinmetz, Viken, & 
Rose, 1999) and on absolute startle reflex but not emotion-modulated startle reflex (Anokhin, 
Golosheykin, & Heath, 2007; see also Carlson, Katsanis, Iacono, & McGue, 1997). Research on 
the heritability of these psychophysiological indices is needed to establish their potential as 
endophenotypes for FA-INT disorders. 
 The amygdala is the primary brain structure for processing fear, and it has been linked to 
behavioral inhibition (Haas, Canli, Haas, & Canli, 2008; Kensinger & Corkin, 2004; Morgan & 
Morgan, 2006), suggesting neural substrates implicated in the functioning of the amygdala are 
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also potential endophenotypes for FA-INT disorders and their precursors. Pharmacological 
studies indicate that blockage of receptors in the amygdala (e.g., N-methyl-D-aspartate, NMDA, 
receptors) inhibits fear responses and consolidation of fear memories, and NMDA antagonists 
successfully treat various anxiety disorders (Garakani, Mathew, & Charney, 2006). Impairment 
in amygdala functioning is also implicated in nonfear disorders (e.g., MDD), but genes 
associated with  functioning of the amygdala receptors and neurotransmitters that bind to these 
receptors likely contribute considerably to the PH liability. Research showing associations 
between anxiety disorders and measures of heart rate variability and respiratory sinus arrhythmia 
in response to emotion-laden stimuli (e.g. Licht et al., 2009; Porges, 2011) suggest the 
physiological substrates underlying parasympathetic functioning may also be key 
endophenotypes.  
 2.2.2.2 Negative Thought Processes Liability. Twin studies have demonstrated substantial 
genetic covariance between MDD and GAD, and a significant proportion of that genetic overlap 
is due to the common genetic liability for NE (Hettema, Neale et al., 2006; Kendler, Gardner, 
Gatz, & Pedersen, 2007; Middeldorp, Cath, Van Dyck, & Boomsma, 2005). Nevertheless, 
Hettema et al. (2006) found a significant genetic factor shared among MDD, GAD, and PD that 
was independent from the genetic influences of neuroticism, and Kendler et al. (2007) found that 
only about 25% of the genetic correlation between MDD and GAD was shared with neuroticism, 
leaving a considerable amount of shared genetic variation to be explained by other factors. We 
propose that the comorbidity among the disorders in the INT-AM subfactor are explained by a 
genetic predisposition for various interrelated negative thought (NT) processes that have 
empirical links to depression and anxiety, including attentional biases to threatening and sad 
stimuli, excessive contemplation of negative information, difficulty shifting attention away from 
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negative information, and trouble suppressing pessimistic cognitions (e.g., Bradley, Mogg, 
White, Groom, & de Bono, 1999; Everaert, Koster, & Derakshan, 2012; Gotlib & Joormann, 
2010; Hirsch, Clark, & Mathews, 2006; Mathews & MacLeod, 2005; Mogg, Philippot, & 
Bradley, 2004; Vanderhasselt, et al., 2012; Zetsche, D'Avanzato, & Joormann, 2012). This 
predisposition underlies cognitive characteristics of these disorders, like worry, rumination, 
hopelessness, and negative attributions about the self and the future (e.g., Alloy et al., 2004; 
Nolen-Hoeksema, Wisco, & Lyubomirsky, 2008; Papageorgiou, 2006), as well as anhedonia and 
low levels of positive affect which are also characteristics of these disorders (Krueger, 1999a; 
Watson, 2005). Individuals with an INT-AM disorder inherit both the NE liability and the NT 
liability and thus are prone to high levels of fear, anger, and sadness and to maladaptive 
cognitive processing and internal regulation of these negative emotions. 
 This cognitively based NT liability is consistent with the many cognitive theories of 
depression and anxiety, such as Beck’s cognitive distortion model (Beck, 1967; 1976), the 
learned helplessness and hopelessness models (Abramson, Metalsky, & Alloy, 1989; Abramson, 
Seligman, & Teasdale, 1978; Seligman, 1974), Eysenck’s hypervigilance theory of anxiety 
(Eysenck, 1992; 1997), and Beck’s information processing model of anxiety (Beck & Clark, 
1997). Furthermore, the combination of NE and NT liabilities is supported by transdiagnostic 
emotion regulation models that propose maladaptive cognitive regulation of negative emotions 
contribute to depression and anxiety (Aldao & Nolen-Hoeksema, 2010; Gross & Thompson, 
2007; Hofmann, Sawyer, Fang, & Asnaani, 2012) and findings that cognitive processes, such as 
attentional biases toward threatening stimuli, moderate associations between behavioral 
inhibition and internalizing problems (e.g., Fox & Pine, 2012; Pérez-Edgar et al., 2011).  
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 Although few studies have investigated the heritability of the many cognitive constructs 
associated with depression and anxiety, the few existing studies generally support moderate 
genetic influences on these constructs. Attributional style, a cognitive pattern characterized by 
internal, global, and stable attributions for negative events, was found to be moderately heritable 
(35%; Lau, Rijsdijk, & Eley, 2006) in a sample of adolescents, and anxiety sensitivity, which 
refers to beliefs about the harmful consequences of anxiety, was also moderately heritable in 
samples of adolescents (60%; Eley & Brown, 2004) and adults (45%; Stein, Jang, & Livesley, 
1999). Eley and colleagues studied genetic influences on various simple cognitive variables in 8-
year-old children. They found significant genetic influences on anxiety sensitivity (37%; Eley, 
Gregory, Clark, & Ehlers, 2007) but negligible genetic influences and significant shared 
environmental on negative interpretations of interpersonal relationships (Gregory et al., 2007). 
Genetic influences on anxiety sensitivity were highly correlated with genetic influences on 
panic/somatic symptoms of anxiety in children (Eley et al., 2007), and genetic influences on a 
measure of children’s interpretations of situations as either negative or neutral were significantly 
correlated (r =.65) with genetic influences on children’s depressive symptoms (Eley et al., 2008).  
 Like the BD and PH liabilities, the NT liability should be conceptualized in a 
developmental context as behavioral tendencies, temperament traits, and physiological processes 
begin to emerge in childhood and predispose individuals to develop INT-AM disorders. 
Although the ability to internally regulate emotions emerges in the first year of life (e.g., self-
soothing), self-regulation abilities continue to develop rapidly through the critical preschool 
years and into childhood and adolescence (Cole, Michel, & Teti, 1994; Gralinski & Kopp, 1993; 
Kaler & Kopp, 1990; Rothbart, Posner, & Rosicky, 1994). Young children, who lack the 
cognitive abilities to develop stable expectancies and explanations for stress and negative 
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emotions, express maladaptive internal regulation as behavioral restraint, shyness, and low 
attention regulation (Cicchetti & Tucker, 1994; Eisenberg et al., 2001; Nolen-Hoeksema, Girgus, 
& Seligman, 1992; Turner & Cole, 1994). Improved cognitive abilities during late childhood and 
adolescence allow for the development of more stable and pathological cognitive styles, such as 
pessimistic beliefs about causes and consequences of stressful events and hopelessness about the 
future (Kaslow, Adamson, & Collins, 2000; Nolen-Hoeksema et al., 1992). By early 
adolescence, rumination, poor ability to shift attention away from aversive or negative stimuli 
when desired, high self-criticism, dysfunctional interpretation schemas, hopelessness about the 
future, and negative views of self, world, and future are associated with higher levels of 
internalizing problems (Bachanas & Kaslow, 2001; Murisa, Meesters, & Blijlevens, 2007; 
Oldehinkel et al., 2004; Silk et al., 2003). 
 With respect to endophenotypes, studies linking depression and anxiety to genes related 
to serotonergic modulation of the stress response (e.g., serotonin transporter gene; Holmes, 2008; 
Koller et al., 2008) and genes linked to HPA axis regulation (e.g., glucocorticoid receptor gene; 
Brouwer et al., 2006; Papiol et al., 2007) suggest that biological markers of HPA axis and 
serotonergic system functioning may be promising INT-AM disorder endophenotypes. Complex 
interactions between genetic susceptibility to serotonergic and noradrenergic system dysfunction 
and stress-related changes in the HPA axis have been implicated in the etiology of depression 
(Firk, Markus, Firk, & Markus, 2007; Porter et al., 2004), and psychopharmacological treatment 
studies support the role of reduced neurotransmission of serotonin and norepinephrine in the 
pathophysiology of GAD (Nutt, Argyropoulos, Hood, & Potokar, 2006). Despite the extensive 
body of research linking corticotrophin-releasing factor and the HPA axis to depression (Hankin, 
Badanes, Abela, & Watamura, 2010; Nemeroff & Vale, 2005; Wardenaar, et al., 2011), almost 
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no research has investigated the role of the HPA axis in the etiology of GAD separate from the 
INT-FA anxiety disorders. Although findings of associations between the HPA axis functioning 
and anxiety disorders in general have been mixed (Risbrough & Stein, 2006), evidence from a 
study of HPA functioning in GAD patients showed significant changes in plasma cortisol 
following cognitive treatment (Tafet, Feder, Abulafia, & Roffman, 2005).  
2.3 Molecular Genetics: Identifying Genes 
 At present, the specific genes associated with the NE, BD, PH, and NT liabilities are 
unknown, and thus we limit our discussion of candidate genes to a few brief comments. 
Interpreting research on candidate genes for psychiatric disorders and personality traits is 
complicated because effects are likely due to multiple genes, each of which has small effects. 
Very large samples, replication across samples, and strong biologically informed a priori 
hypotheses are needed to place candidate gene findings on solid footings, and even then there is 
reason to be cautious regarding the likelihood that reported effects are not false-positive errors, 
especially when testing for gene x environment interactions (Duncan & Keller, 2011). 
Nevertheless, promising leads are being developed, and findings from molecular genetic studies  
support common genetic liabilities. Studies support over-transmission of the risk variants of 
various genes in individuals with different psychiatric disorders. For example, the muscarinic 
acetylcholine receptor M2 gene (CHRM2) is involved in the stress response system among other 
functions (e.g., attention, learning, memory and cognition) and has been linked to alcohol and 
drug dependence (Wang et al., 2004), a general composite externalizing factor (Dick et al., 
2008), and depression (Comings et al., 2002). In addition, findings regarding genes involved in 
SUDs (e.g., related to dopamine functioning) have also been implicated in BD traits like 
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impulsivity and risk taking (Hiroi & Agatsuma, 2005; Kreek, Nielsen, Butelman, & LaForge, 
2005) and the association between neuroticism and SUDs (Ellis et al., 2011).  
3. Environmental Mediation and Moderation of Genetic Liabilities 
 Environmental factors are also important to the etiology of mental disorders and thus may 
contribute to comorbidity. In the common liabilities model, environmental risks are depicted as 
coalescing under a general factor that is influenced by the genetic liabilities and influences both 
INT and EXT psychopathology. By and large, environmental risks overlap extensively across 
disorders and EXT/INT factor groups. For example, low family support, conflict with peers, peer 
pressure, and broken relationships are associated with risk for substance use and depression in a 
sample of adolescents (e.g., Aseltine, Gore, & Colten, 1998). Nevertheless, some environmental 
risk factors are likely to influence certain disorders to a greater degree than other disorders, and 
thus contribute to disorder specific effects, for example, peer pressure may be a stronger 
predictor of substance use and conflict with friends may be a stronger predictor of depression 
(Aseltine et al., 1998). Consistent with largely shared but some specific environmental effects, 
findings from a multivariate twin study suggest that factor-specific environmental risks do not 
distinguish INT disorders from EXT disorders, although some environmental influences are 
likely specific to smaller subsets of disorders, such as CD and ASPD and MDD, GAD, and 
alcohol dependence (Kendler, Prescott et al., 2003). 
 The influence of environmental risk mechanisms on comorbidity is due in part to the 
tendency for multiple environmental risks to co-occur. For example, exposure to interparental 
conflict in the home is related to conflict with peers and peer rejection (Hipwell, Murray, 
Ducournau, & Stein, 2005; Kunz, 2001), and exposure to criminal and violent acts, deviant 
peers, and drug accessibility (all risk factors for both substance use and depression) tend to co-
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occur in the same neighborhoods (Curry et al., 2008; Stockdale et al., 2007; Valdez, Kaplan, & 
Curtis, 2007). “Environmental” risk factors, such as family conflict and affiliation with deviant 
peers, have been found to be genetically influenced (McGue, Elkins, Walden, & Iacono, 2005; 
Plomin & Bergeman, 1991; Tarantino et al., 2014), and thus genetic factors may also contribute 
the co-occurrence of multiple environment risks.  
 Research supports the “cumulative risk hypothesis” that added exposures to multiple 
risks across different stages of development convey greater risk than single exposure or exposure 
in a single developmental period. This repeated exposure to environmental risks also amplifies 
gene expression through gene-environment (G-E) interplay (Rutter & Silberg, 2002), which 
contributes to increased heritability of most mental disorders with age (Bergen et al., 2007). 
Gene-environment correlation is one mechanism of G-E interplay that contributes to comorbidity 
(Jaffee & Price, 2007). Genetic and environmental risks are correlated because parents transmit 
risk to offspring both by passing on genes to their offspring and by shaping their offspring’s 
environment (contributing to “passive” G-E correlations) and because genetically influenced 
behavior directly influences the environment (contributing to “active” G-E correlations). For 
example, genetic liability to BD increases risk for both EXT disorders and exposure to 
environmental factors like parental conflict and affiliation with defiant peers (Keyes et al., 2007), 
which are nonspecific environmental factors that potentiate risk for EXT and INT disorders. 
 Environmental factors also interact with genetic factors to increase or decrease risk for 
disorders. For example, genetic influences on substance use and deviant behaviors are amplified 
in urban settings where environmental risks (e.g., easy access to drugs, exposure to violence, and 
perhaps less parental monitoring) are more common than in rural environments (Legrand, Keyes, 
McGue, Iacono, & Krueger, 2007; Rose, Dick, Viken, & Kaprio, 2001). As follows, 
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environmental risks may also contribute to comorbidity by increasing the likelihood that 
common and disorder-specific genetic liabilities are expressed as mental disorders. Thus, genes 
and the environment influence each other and risk for disorders in a complex, reciprocal ways, 
and, importantly, because neither the genetic nor the environmental risk factors are disorder-
specific, these G-E interplay mechanisms contribute to comorbidity of mental disorders. 
4. Explaining Co-occurrence of SUDs and Other Disorders 
Our common liabilities model explains comorbidity among mental disorders in general. 
In this section, we focus on how the model explains comorbidity with SUDs in particular and 
highlight some important assumptions of the model. The degree of influence of a given 
mechanism on the comorbidity of SUDs with another disorder varies from disorder to disorder. 
Likewise, the mechanism underlying the co-occurrence of two disorders in a given individual 
varies from person to person. Characteristics of the two disorders, such as age of onset and 
temporal order of emergence of the disorders, provide insight about the mechanisms underlying 
comorbidity. 
4.1 Behavioral Disinhibition Liability: Link between SUDs and Antisocial Disorders 
 The model proposes that the BD genetic liability is the most likely factor underlying the 
comorbidity of SUDs with antisocial behavior disorders, and that when SUDs are comoribid with 
antisocial disorders the age of initiation of substance use is typically during early adolescence. 
As we have previously discussed, the typical progression of externalizing problems related to the 
BD liability is (a) impulsivity, inattention, and aggressiveness during early childhood; (b) 
disruptive behavior disorders during childhood; (c) antisocial behaviors, initiation of substance 
use, precocious sexual activity, affiliation with deviant peers, and parent-child conflict during 
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early to mid-adolescence; and, finally (d) finally the emergence of alcohol and drug 
abuse/dependence and ASPD in adulthood (Iacono et al., 2008). 
 In a review of comorbidity of SUDs in samples of youth, Armstrong and Costello (2002) 
report that approximately 60% of youth with an SUD have a comorbid disorder, and early-onset 
SUDs are most often comorbid with CD and oppositional defiant disorder (Armstrong & 
Costello, 2002). A longitudinal study of childhood internalizing and externalizing disorders and 
early adolescent substance use supports this idea. King, et al., (2004) found that disruptive 
behavior disorders (CD, ODD, and, to a lesser extent, ADHD) in male and female 11-year-olds 
were robust predictors of age 14 substance use behaviors (e.g., use of alcohol, cigarette, and 
cannabis one or more times per month and being drunk; King, Iacono, & McGue, 2004). MDD 
and anxiety disorders were much less consistently predictive of substance use behaviors at age 
14. Thus, through a developmental progression of expressed externalizing traits, behaviors, and 
environmental risks, the comorbidity of SUDs with CD and ASPD is most likely influenced 
through a general genetic liability to BD. 
4.2 General NE liability: Link between Alcohol Use Disorder and Anhedonia/Misery Disorder 
 In the model, the NE liability has its greatest influence on INT disorders, particularly the 
INT-AM disorders, and the model proposes that NE also has a strong effect on alcohol use 
disorder (AUD) and contributes to the high comorbidity between alcoholism and depression. 
Several lines of research support this idea. First, although alcohol dependence has a stronger 
loading on the EXT factor than the INT factor, there is evidence from twin studies that 
nevertheless suggests some shared latent covariance between alcohol dependence and the INT 
factor (Kendler, Prescott et al., 2003; King et al., 2004; Krueger et al., 2001). Second, twin 
studies have demonstrated that genetic factors underlie the comorbidity of depression and 
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alcohol dependence (Kendler, et al., 1993; Prescott, Aggen, & Kendler, 2000). Third, although 
high negative emotionality has been associated with substance dependence in general (Krueger, 
1999a), it appears to have an especially strong association with AUD. McGue and colleagues 
(1997; 1999) found that alcohol dependence is particularly common among individuals who have 
high levels of both behavioral disinhibition and negative emotionality and that alcohol 
dependence is primarily associated with negative emotionality, while illicit drug use disorders 
are primarily associated with constraint (McGue, Slutske, & Iacono, 1999; McGue, Slutske, 
Taylor, & Iacono, 1997). Similarly, Elkins et al. (2004) found that adolescent offspring of 
parents with a history of alcohol dependence scored significantly higher on negative emotionality 
than adolescents with no parental history of alcohol dependence, and negative emotionality did 
not differ for offspring of parents with and without a drug abuse/dependence history (Elkins, 
McGue, Malone, & Iacono, 2004). They found that this pattern characterized both offspring with 
an SUD and those who had not yet developed an SUD, which supports negative emotionality as 
an indicator of familial risk for alcoholism.  
 Fourth, research suggests that understanding how the NE liability mechanism contributes 
to the comorbidity of SUDs and internalizing disorders requires studying specific negative 
emotions (e.g., Lara, Pinto, Akiskal, & Akiskal, 2006). Findings suggest that irritability and 
anger are associated with both alcohol use and depression but not with anxiety  
(Fava, et al., 2010; Hussong & Chassin, 1994; Lara et al., 2006; Pardini et al., 2004; Tarter, 
Blacksona, Brighama, Mossa, & Caprarab, 1995). These findings suggest that NE-related 
proneness toward irritability and anger may underlie the comorbidity of alcohol dependence and 
internalizing disorders within the INT-AM factor specifically. The proneness toward irritability 
and anger is likely influenced by disorder-specific genetic and environmental factors and perhaps 
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by the environmental factors that Kendler et al. (2003) found were shared among MDD, GAD, 
and alcohol dependence. The factors underlying the comorbidity of alcohol dependence with 
INT-FA disorders would likely be different and perhaps involve specific effects that remain to be 
identified.  
4.3 Environmental Mechanisms 
 Environmental factors likely contribute to the comorbidity of SUDs with both INT and 
EXT disorders through shared environmental risk factors, the tendency for multiple 
environmental risks to co-occur, and G-E interplay. We expect, though, that environmental risk 
factors are relatively more influential than genetic factors when the comorbid SUD has a late 
onset and the relative influence of environmental factors to genetic factors is greater for the 
comorbidity between SUDs and INT disorders than SUDs and EXT disorders. Because the BD 
liability is likely to be expressed as substance use relatively early in adulthood or even in 
adolescence, it is less likely that the SUDs with a late age of onset are strongly influenced by this 
genetic liability. Although the NE liability contributes to comorbidity between INT disorders and 
SUDs, research also suggests that stress, particularly chronic stress over time, and the 
neurobiological effects of chronic stress response systems (e.g., on HPA system functioning) 
plays an important role in  the comorbidity of internalizing disorders and SUDs (Brady & Sinha, 
2005).  
4.4 Other Explanations for Comorbidity 
 Other explanations for the comorbidity of SUDs with other disorders are also supported 
by research. One commonly posited explanation is directional or reciprocal causality in which 
one disorder or the consequences of the disorder (e.g., neuroadaptations associated with chronic 
drug use) cause a second disorder, and these causal links may be reciprocal. Several lines of 
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research support this explanation. First, internalizing (e.g., MDD, PD) and externalizing 
disorders (e.g., CD, ODD) have been found to prospectively predict SUDs and vice versa 
(Breslau, Novak, & Kessler, 2004; Fergusson, Boden, & Horwood, 2009; Goodman & 
Capitman, 2000; Greenfield et al., 1998; Kushner, Sher, & Erickson, 1999; Marmorstein & 
Iacono, 2011; Marmorstein, Iacono, & Malone, in press; Rao et al., 2000). These findings are 
consistent with directional causality, but findings of directionality do not necessarily imply 
causation and also do not rule out a common liability explanation for comorbidity. 
 Second, when depressive or anxiety disorders precede SUDs, a common explanation is 
the “self-medication” theory, which proposes that individuals begin using substances to “treat” 
symptoms of a primary disorder. For example, nicotine dependence co-occurs with depression, 
and smoking results in marked reductions in brain levels of monoamine oxidase A (MAO-A; 
Fowler et al., 1996), an enzyme that degrades serotonin and norepinephrine. MAO inhibitors are 
antidepressant drugs that block this process (Adli et al., 2008), suggesting that smoking, too, may 
have an antidepressant effect. The self-medication theory, though, is challenged by findings that 
SUDs often precede internalizing disorders (Fergusson, et al., 2009; Marmorstein, et al., 2010; 
Rao et al., 2000) and by a study that used biometric modeling to compare etiological models for 
the comorbidity of nicotine dependence and depression and found support for a correlated or 
shared familial liability (perhaps a common NE liability) rather than for one disorder leading to 
the other (Johnson, Rhee, Chase, & Breslau, 2004).  
 Third, longitudinal studies of adolescent and young adults have found that episodes of 
depression and substance use tend to occur in close temporal proximity (Fergusson, et al., 2009; 
Rao et al., 2000). This research may indicate bidirectional influence of symptoms of the 
comorbid disorders but may also be explained by common environmental triggers, greater use of 
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substances when feeling depressed among individuals who have a common genetic liability for 
both disorders, or negative consequences of one of the disorders (e.g., failing grades, strained 
interpersonal relationships) increasing symptoms of the other disorder. Fourth, when SUDs are 
comorbid with another condition, SUD symptoms tend to be more severe (Conway et al., 2006; 
Grant et al., 1996), durations of remission and time to relapse are shorter (Greenfield et al., 1998; 
Hasin et al., 2002), and treatments are less effective unless there is conjunctive treatment for the 
comorbid disorder (Myrick & Brady, 2003). These findings may indicate that the comorbid 
disorder exacerbates (or is causally linked to) SUD symptoms, but these findings may also 
suggest a common genetic liability that underlies more severe, chronic, treatment-resistant 
symptoms of both disorders. 
  In summary, these lines of research are consistent with directional and reciprocal 
causality but are also compatible with a common liabilities model. These two explanations for 
comorbidity are not mutually exclusive, and both likely contribute to comorbidity in complex 
ways. To be more specific, the presence of a genetic liability does not determine that a disorder 
will develop but rather increases the likelihood that a disorder will develop given the presence of 
other genetic and environmental risk factors, which may include other psychiatric disorders. For 
example, a common genetic liability for NE increases the likelihood of developing both AUD 
and social anxiety disorder, and the liability may be expressed first as social anxiety symptoms 
which in turn casually contribute to the liability being expressed as alcohol dependence. The 
causality explanation is also likely complicated and mediated by changes in environmental risks 
(e.g., unemployment, strained interpersonal relationships, unhealthy compensatory strategies 
used to manage the primary disorder) and changes in the individual that are probably genetically 
influenced to some degree (e.g., changes in brain structures and functions, cognitive processes). 
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Both common liabilities and causal relationships between comorbid disorders likely contribute to 
the noted strong correlations between the INT and EXT factors and the subfactors and among the 
individual disorders. Therefore, the hierarchical common liabilities model is not intended to be 
exhaustive or exclusive of other explanations for comorbidity but rather to integrate important 
findings about phenotypic covariance, genetics, environmental influences, biological systems, 
and developmental changes. 
5. Conclusion 
5.1 Summary 
 The etiology of mental disorders is increasingly understood to involve many interacting 
genes and environmental factors. Individual pathways of risk begin with general genetic 
liabilities that, throughout development, interact with environmental factors and other genetic 
factors and result in increased likelihood of developing some mental disorders and decreased 
likelihood of developing other disorders. This chapter provided a review of research on 
comorbidity with SUDs and proposed an integrative hierarchical model based on phenotypic 
covariance and latent genetic liabilities to explain observed patterns of disorder co-occurrence. 
The highest order factor, NE, increases risk for all INT and EXT mental disorders included in 
Figure 1. In other words, individuals with these mental disorders are likely to share, to varying 
degrees, the genetic liability for NE, with any particular disorder they develop shaped by the 
presence of other genes (e.g., genes affecting liability for disorders associated with BD) and 
environmental factors. The comorbidity of disorders increases as the number of shared genetic 
liabilities and shared environmental influences increases. Disorders falling in the same INT/EXT 
spectra have high comorbidity because individuals with these disorders are likely to inherit not 
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only the NE liability but also a more specific genetic liability that is shared by disorders in the 
spectrum.  
Further differentiation occurs because each disorder in the model is also influenced by 
specific effects that are unique to the disorder and account for the development of different 
disorders among individuals who share these higher order liabilities. These specific genetic and 
environmental effects differ in nature across the disorders, and the proportion of genetic to 
environmental influence unique to a disorder varies from one disorder to another. Using 
multivariate twin modeling, Kendler et al. (2003) found that disorder-specific loadings for 
unique (i.e., not shared among family members) environmental influences on these common 
mental disorders were substantial, whereas environmental influences shared among family 
members were very small. The magnitude of disorder-specific genetic loadings varied across 
disorders with substantial loadings found only for alcohol dependence and drug 
abuse/dependence, suggesting that these specific effects are largely environmental. As follows, 
genetic and environmental influences at the higher levels of the hierarchy explain comorbidity 
among different disorders and specific genetic and environmental influences at the lowest level 
of the hierarchy account for multifinality and the etiology of individual disorders.  
5.2 Limitations 
 Despite the breadth and comprehensiveness of this model, it does not attempt to account 
fully for mental disorder co-occurrence or to exclude other mechanisms that may also contribute 
to comorbidity (e.g., one disorder causing the other). The model focuses on common disorders 
that have typically been assessed in epidemiologic and behavior genetics investigations that 
examine the underlying structure of psychopathology and thus are known to have shared 
covariance with other INT or EXT disorders. Consequently, some disorders (e.g., posttraumatic 
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stress disorder, personality disorders besides ASPD, psychotic disorders, bipolar disorders) are 
not included in the model. In addition, the model does not distinguish among different illicit drug 
use disorders. Further, relevant moderating variables, such as gender, ethnicity, and family 
history of psychopathology, are not included in the model but would improve the specificity of 
the model for understanding comorbidity in distinct groups and under various conditions. It is 
important to note, though, that although there are well-known gender differences in the mean 
level of EXT and INT attributes, many studies find no gender effects pointing to differences in 
the etiology of mental disorders, for example, in the hierarchical factor structures of 
psychopathology (Krueger, 1999b), the structure of genetic and environmental influences on 
externalizing disorders (e.g., Hicks et al., 2007; Kendler, Prescott et al., 2003), heritability of 
disorders (Heath et al., 1997; Sullivan et al., 2000), and relationships between personality or 
temperament and psychopathology (Oldehinkel et al., 2004).  
5.2 Implications and Future Directions 
The goal of this chapter was to propose an integrative, research-derived model that 
provides an organizational framework for guiding future research on the origins of comorbid 
mental disorders. Although the structure and components of the model are all empirically 
derived, some components have more empirical support than others. The liability to persistent 
negative thinking, for example, is certainly consistent with theoretical models of depression and 
anxiety and findings of characteristic negative thinking patterns in depressed and anxious 
individuals, but almost no research has investigated the genetic basis of these negative thinking 
patterns, the genetic covariation between these thinking patterns and internalizing 
psychopathology, or endophenotypes related to these constructs. Better phenotypic 
characterization of the behaviors, traits, and cognitive processes associated with these genetically 
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influenced liabilities and research on the genetic covariation between these liabilities and 
psychopathology will advance our understanding of the structure underlying comorbidity of 
mental disorders. These broad phenotypes can then be used in the search for specific genes 
associated with psychopathology and, when studied in conjunction with specific disorders, will 
ultimately lead to delineation of the etiology and biological processes shared among comorbid 
disorders and biological processes that distinguish mental disorders. In addition, research on 
endophenotypes for the liabilities is lacking and is important for linking the neurobiological, 
genetic, and phenotypic findings to better understand the diverse, complex, interacting systems 
that contribute to comorbidity. Studies that use an interdisciplinary approach to investigating the 
interplay of genetics, neurobiological systems, and environmental factors will be key to 
understanding comorbidity. 
This model can also be used to guide research on the genetic and environmental factors 
underlying psychopathology more broadly defined. Feinstein (1970), who coined the term 
comorbidity, originally described a broad construct that referred to comorbidity not just among 
medical disorders but also among symptoms of disorders and other clinical phenomena that do 
not meet criteria for disease status (Feinstein, 1970; Krueger & Markon, 2006). Krueger (2002, 
2005) and others have provided evidence that psychopathology is best conceptualized along 
continuous dimensions, rather than as discrete entities (Krueger, et al., 2005; Krueger & 
Piasecki, 2002). In fact, psychopathology researchers have debated use of the term 
“comorbidity” to describe mental disorders and how to best conceptualize the observed co-
occurrence of mental disorders. Lilienfeld et al. (1994) and others discussed concerns that the 
term comorbidity inappropriately reifies psychopathology as defined by discrete, well-
understood categorical diagnoses with distinct etiologies rather than conceptualizing it in a 
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dimensional framework (Lilienfeld, Waldman, & Israel, 1994; Meehl, 2001), while others have 
argued that the concept of comorbidity is useful even when categories do not have clearly 
distinct etiologies (Spitzer, 1994).  Krueger and Markon (2006) raise the related concern that co-
occurrence of two legitimate diagnoses in a single individual should be distinguished from 
correlation or covariation of diagnoses in a group of people (Krueger & Markon, 2006). 
Regardless of whether or not the term “comorbidity” and discrete diagnostic categories are used, 
the empirical evidence and the proposed common liability model suggest that advancing our 
understanding of the origins of comorbidity (or “co-occurrence") requires broadening our 
conceptualization of this phenomenon to include not only diagnoses or dimensional measures of 
psychopathology but also related personality traits, behavioral tendencies, and neurobiological 
systems. It requires studying these broad factors from a developmental perspective in order to 
understand developmental differences in the expression of genetic liabilities, the progression of 
risk from early appearances of problems to impairing psychopathology, and how genetic and 
environmental interplay affects the course of comorbid disorder development. Finally, it implies 
that efforts to find genes for SUDs and related psychopathology would do well to capitalize on 
what we know about comorbidity. That is, rather than only trying to find genes for specific 
SUDs, efforts directed at finding genes associated with the covariance among disorders are also 
needed. Because behavior genetic studies have shown that the latent traits underlying this 
covariance are more heritable than the individual characteristics comprising it, gene finding 
approaches targeting the latent traits have strong payoff potential. 
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Figure Caption 
 
An integrative model that explains comorbidity among substance use disorders and other 
common mental disorders through a hierarchical structure of general and disorder-specific 
genetic and environmental effects. A broad externalizing factor represents the covariance among 
conduct disorder, antisocial personality disorder, tobacco use disorder, drug use disorders, and 
alcohol use disorder, and a broad internalizing factor represents the covariance among depressive 
and anxiety disorders. The internalizing factor is further divided into two subfactors: (1) an 
anhedonia/misery factor that represents the covariance among major depressive disorder, 
persistent depressive disorder, and generalized anxiety disorder; and (2) a fear/arousal factor that 
represents the covariance among specific phobia, social anxiety disorder, and agoraphobia. Panic 
disorder loads onto both internalizing subfactors. These internalizing and externalizing factors 
derive from genetically influenced biological predispositions/liabilities, each of which is 
expressed as a spectrum of related personality traits, cognitive processes, and behavioral 
tendencies. At the highest level of the hierarchy, a liability to negative emotionality (NE; 
proneness to experiencing negative emotions, tendency toward dysregulation) influences risk for 
both externalizing and internalizing disorders. The NE liability has particularly strong loadings 
(bold lines) on the internalizing factor and on alcohol use disorders and thus is a substantial 
contributor to comorbidity among internalizing disorders, as well as between internalizing 
disorders and alcohol use disorders. Negative emotionality has a smaller effect on comorbidity 
between INT disorders and other externalizing disorders. At the next level of the hierarchy, a 
liability to behavioral disinhibition (BD; undercontrolled behavior, low levels of persistence, 
aggressiveness, impulsivity, inattention) underlies risk for disorders in the externalizing factor. A 
liability to negative thought processes (NT processes; low positive affect, habitual negative 
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attributions and expectations, biased attention and memory, worry, rumination) contributes to 
risk for the anhedonia/misery disorders. A liability to physiological arousal (PH; 
psychophysiological/somatic signs, fear, heightened attention to threats, behavioral inhibition) 
influences risk for fear/arousal disorders. Environmental risks are influenced by the genetic 
liabilities (e.g., BD contributes to affiliation with deviant peers) and also contribute to the 
etiology of internalizing and externalizing disorders. Some environmental factors (e.g., stressful 
and traumatic events, negative parent–child relations, exposure to parents’ psychopathology) 
contribute to risk for both externalizing and internalizing disorders, whereas other environmental 
factors are likely to have a greater influence on either the externalizing factor (e.g., neighborhood 
crime and availability of substances, deviant peer affiliation) or the internalizing factor (e.g., 
social rejection, peer conflict). At the lowest level of the hierarchy, unique genetic and 
environmental risks specific to each disorder (SE; specific effects) explain why individuals with 
the same general liability do not all have the same outcomes. The cumulative effects of gene-
environment interplay across development lead to the emergence of mental disorders, and the 
hierarchical structure of genetically influenced liabilities contributes to covariance among 
disorders and the observed pattern of comorbidity. 
 
